Impact of the haplotypes of the human pregnane X receptor gene on the basal and St John's wort‐induced activity of cytochrome P450 3A4 enzyme
- 23 February 2009
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 67 (2) , 255-261
- https://doi.org/10.1111/j.1365-2125.2008.03344.x
Abstract
Human pregnane X receptor (PXR/NR1I2) is a key regulator of cytochrome P450 3A4. To date, there are 198 reported SNPs for the human PXR/NR1I2 gene. Some of these SNPs are found to affect the inducing ability of PXR to CYP3A4. This study, for the first time, has investigated the effect of PXR haplotype on basal and St John's wort-induced CYP3A4 activity in humans. H1/H1 of the PXR gene had weaker basal transcriptional activity but greater inducible transcriptional activity to CYP3A4 than H1/H2 and H2/H2. Human pregnane X receptor (PXR/NR1I2) is the master regulator of CYP3A4, which metabolizes >50% of drugs on the market. This study investigated the relationship between the two most frequent haplotypes [H1 (TCAGGGGCCACC) and H2 (CCGAAAACTAAT)] of PXR and basal and St John's wort (SJW)-induced CYP3A4 activity. Ten healthy subjects carrying H1 and H2 haplotypes (three subjects with H1/H1, four with H1/H2 and three with H2/H2) entered this study. The 10 subjects did not carry CYP3A4*4, *5 and *6. All subjects were administrated a 300-mg SJW tablet three times daily for 14 days, and CYP3A4 activity was measured using nifedipine (NIF) as a probe. The plasma concentrations of NIF and dehydronifedipine (DNIF) were determined by a validated liquid chromatography/mass spectrometry/mass spectrometry method. After administration of SJW, the AUC(0-infinity) of NIF decreased significantly, and the AUC(0-infinity) of DNIF increased significantly (P < 0.05). For H1/H2, the AUC(0-infinity) of NIF decreased by 42.4%, and the AUC(0-infinity) of DNIF increased by 20.2%; for H2/H2, the AUC(0-infinity) of NIF decreased by 47.9%, and the AUC(0-infinity) of DNIF increased by 33.0%; for H1/H1, the AUC(0-infinity) of NIF decreased by 29.0%, yet the AUC(0-infinity) of DNIF increased by 106.7%. The increase of the AUC(0-infinity) of DNIF in H1/H1 was significantly different from the other two haplotype pairs (P < 0.05). Meanwhile, before administration of SJW, the ratio of AUC(0-infinity(DNIF))/AUC(0-infinity(NIF)) was the lowest for H1/H1 (22.1%), compared with H1/H2 (58.7%) and H2/H2 (30.0%). H1/H1 of the human PXR gene had weaker basal transcriptional activity but greater inducible transcriptional activity to CYP3A4 than H1/H2 and H2/H2.Keywords
This publication has 26 references indexed in Scilit:
- Identification of NR1I2 genetic variation using resequencingEuropean Journal of Clinical Pharmacology, 2007
- Pregnane X Receptor: Promiscuous regulator of detoxification pathwaysThe International Journal of Biochemistry & Cell Biology, 2007
- International Union of Pharmacology. LXII. The NR1H and NR1I Receptors: Constitutive Androstane Receptor, Pregnene X Receptor, Farnesoid X Receptor α, Farnesoid X Receptor β, Liver X Receptor α, Liver X Receptor β, and Vitamin D ReceptorPharmacological Reviews, 2006
- PXR and CAR: Nuclear Receptors which Play a Pivotal Role in Drug Disposition and Chemical ToxicityDrug Metabolism Reviews, 2006
- Functional characterization of a novel polymorphism of pregnane X receptor, Q158K, in Chinese subjectsPharmacogenetics and Genomics, 2005
- Population distribution and effects on drug metabolism of a genetic variant in the 5′ promotor region of CYP3A4Clinical Pharmacology & Therapeutics, 1999
- P450 Gene Induction by Structurally Diverse Xenochemicals: Central Role of Nuclear Receptors CAR, PXR, and PPARArchives of Biochemistry and Biophysics, 1999
- A Steroid Receptor Coactivator, SRA, Functions as an RNA and Is Present in an SRC-1 ComplexPublished by Elsevier ,1999
- Noninvasive tests of CYP3A enzymesPharmacogenetics, 1994
- Pharmacokinetics of Oral Nifedipine in Different PopulationsThe Journal of Clinical Pharmacology, 1993